Calquence 100mg Capsule
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of mantle cell lymphoma (MCL) and chronic lymphocytic leukaemia (CLL).
Dosage (summary)
100 mg (1 tablet) twice daily for both MCL and CLL.
Special Populations
- Elderly (u2265 65 years)
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not recommended during pregnancy; avoid breastfeeding during treatment and for 2 days after last dose.
Key Drug Interactions
- Strong CYP3A inhibitors
- Strong CYP3A inducers
Contraindications
- Hypersensitivity to acalabrutinib or excipients
Common side effects
- Infection
- Headache
- Diarrhoea
- Bruising
- Fatigue
Counselling Points
- Take at the same time each day
- Do not take extra doses for missed doses
- Monitor for signs of bleeding or infection
Serious warnings
- Serious haemorrhagic events
- Serious infections
- Cytopenias
- Atrial fibrillation
Important Disclaimer
The Calquence 100mg Capsule professional information leaflet below is the property of Astrazeneca Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
